Skip to main content
. 2021 Jun 25;22(13):6864. doi: 10.3390/ijms22136864

Figure 3.

Figure 3

Possible interventions in intermediate glucose states. DPP4—Dipeptidyl peptidase-4, GLP—1RA-Glucagon-like peptide-1 receptor agonist, TZD—thiazolidinediones.